Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis

OBJECTIVE: The purpose of this study is to determine the efficacy and safety of lenvatinib as second-line therapy in Chinese patients with unresectable hepatocellular carcinoma (HCC). METHODS: We performed a retrospective analysis of Chinese patients with unresectable HCC who received second-line tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, He-nan, Ning, Zhen, Sun, Rui, Jin, Chen-xing, Guo, Xin, Wang, A-man, Liu, Ji-wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723230/
https://www.ncbi.nlm.nih.gov/pubmed/36483048
http://dx.doi.org/10.3389/fonc.2022.1003426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723230/
https://www.ncbi.nlm.nih.gov/pubmed/36483048
http://dx.doi.org/10.3389/fonc.2022.1003426

Ejemplares similares